Novartis

Novartis News

Mankind Pharma reduces price of its heart failure drug by 70 percent in India

Studies show that heart failure claims more than 17.9 million lives every year globally whilst, medicines for critically ill heart…

January 25, 2023 12:39 IST

Alkem, Alkem pharmaceuticals, multiple drug resistance, healthcare news, pharma news,

Sandoz announces agreement to acquire leading antifungal agent from Astellas

The announcement comes after Sandoz successfully completed the acquisition of GSK’s global cephalosporins portfolio in October 2021.

January 24, 2023 11:40 IST

Lupin launches generic version of Novartis’ heart failure drug in India

Studies show that in India, Heart Failure remains one of the most prevalent causes of death in patients suffering from…

January 18, 2023 18:42 IST

Novartis, Heart failure, patent expiry, Indian cardiac market, healthcare news, pharma news,

Novartis’ heart failure drug to go off patent this month; Will this make cardiac care in India affordable?

The affordable versions of the blockbuster drug are expected to hit the market this month and reportedly reduce the cost…

January 15, 2023 16:05 IST

Novartis, iptacopan, oral monotherapy, paroxysmal nocturnal hemoglobinuria, rare blood disorder, health news, pharma news,

Novartis’ investigational drug shows positive outcomes in patients with rare blood disorder

Detailed data will be presented at an upcoming medical meeting and included as part of global regulatory submissions in 2023,…

December 8, 2022 13:12 IST

Novartis’ bad cholesterol drug shows ‘sustained’ efficacy and safety among cardiac patients

According to the company, Leqvio is the first and only small interfering RNA (siRNA) therapy to lower LDL-C and is…

November 8, 2022 11:28 IST

Novartis, Sandoz, essential antibiotics, antibiotics demands, health news, pharma news,

Sandoz to support increased global demand for essential antibiotics; Announces additional investment in manufacturing facility in Austria

The expansion will support a double-digit increase in our future output capacity for penicillins, the company claims.

November 7, 2022 16:45 IST

Novartis’ earning declines 4 percent to $4.28 billion; Outlook of Sandoz improves

Novartis also announced that Richard Saynor, will be appointed CEO designate of Sandoz and step down from the Executive Committee…

October 25, 2022 12:19 IST

Pharmaceuticals, paracetamol, indian pharmaceutical sector, health news, pharma news,

Novartis’ investigational oral monotherapy shows positive results against rare blood disease

The pharma major also claimed that Iptacopan was well tolerated with a favorable safety profile consistent with previously reported data.

October 24, 2022 11:56 IST

Practo, Practo appointments, healthcare, practo clinics, practo hospitals, health news,

Novartis’ prostate cancer drug shows positive results in trial; Gets EMA recommendation

The company claims that the positive CHMP opinion is based on data from the Phase III VISION study, in which…

October 14, 2022 18:48 IST

US Supreme Court, Multiple Sclerosis, Novartis, generic versions, health news, pharma news,

U.S. Supreme Court allows generic versions of multiple sclerosis drug

Reportedly, Novartis sued HEC and more than a dozen other generic drugmakers, accusing them of patent infringement, in Delaware federal…

October 14, 2022 11:18 IST

Novartis unveils new plan based on eight multi-billion dollar brands; To prioritise US market

In a press statement on Thursday, the company said that Novartis is implementing this strategy with a clear focus on…

September 22, 2022 12:28 IST

Novartis plans to petition US Supreme Court to uphold validity of Gilenya dosing regimen patent

In January this year, a three-judge panel of the CAFC issued a decision upholding the validity of the dosing regimen…

September 21, 2022 11:01 IST

Torrent Pharmaceuticals, Torrent Pharma, quarter results, health news, pharma news,

Sandoz announces positive results for its biosimilar denosumab

Denosumab is indicated for treating a variety of conditions, including osteoporosis in postmenopausal women, in men at increased risk of…

September 19, 2022 11:38 IST

Swiss competition commission investigates Novartis over alleged illegal use of patent

Moreover, the pharma company also stated that the COMCO had initiated an investigation in collaboration with the European Commission into…

September 15, 2022 14:38 IST

Novartis to invest $ 300 million in early technical development capabilities for biotherapeutics

The company claims that Novartis’ early-stage biologics portfolio has grown significantly in the last 15 years.

September 13, 2022 10:44 IST

Novartis, Novartis study, hidradenitis, Cosentyx, health news, pharma news,

Novartis’ new drug shows improvement in symptoms among patients with chronic skin condition

Hidradenitis suppurativa is a chronic skin condition that leads to lumps in places such as the armpits or groin. The…

September 10, 2022 14:36 IST

Spectrum Pharmaceuticals, USFDA, lung cancer drug, poziotinib, Luye Pharma, health news, pharma news,

Novartis’ new drug increases survival chances of patients with aggressive breast cancer

The pharma major claims that Kisqali is the only CDK4/6 inhibitor with proven overall survival benefit across all its three…

September 9, 2022 11:26 IST

Pfizer, Pfizer drug portfolio, healthcare news, pharma news,

Novartis to present novel data from its immunology portfolio at international congresses

The pharma major claim that Novartis’s ambition is to reduce the suffering from immunological conditions, which affect up to 4.5…

September 2, 2022 12:47 IST

Novartis, Novartis Global, Novartis Institutes for Biomedical Research, health news, pharma news,

Novartis appoints Fiona Marshall as President of Novartis Institutes for Biomedical Research

Prior to joining Merck in 2018, Dr. Marshall was a Founder and Chief Scientific Officer of Heptares Therapeutics.

September 1, 2022 21:28 IST

Novartis, European Society for Medical Oncology Congress 2022, ESMO 2022, breast cancer, prostate cancer, health news, pharma news,

Novartis to present new data on breast and prostate cancer at ESMO

According to a press statement, from September 10 to September 12, Novartis will present papers on key products which include…

August 30, 2022 11:03 IST

Novartis announces intention to separate Sandoz business to create standalone company

The pharma major also informed that the standalone Sandoz would be headquartered in Switzerland and listed on the SIX Swiss…

August 25, 2022 11:09 IST

Loading…

Something went wrong. Please refresh the page and/or try again.